RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.9094
-0.0796 (-8.05%)
At close: May 29, 2026, 4:00 PM EDT
0.9055
-0.0039 (-0.43%)
After-hours: May 29, 2026, 7:35 PM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $40.98 million as of May 29, 2026. Its market cap has increased by 6.76% in one year.
Market Cap
40.98M
Enterprise Value
28.69M
1-Year Change
6.76%
Ranking
Category
Stock Price
$0.91
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $40.98M, a decrease of -40.31%. That is a compound annual growth rate of -10.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 40.97M | 33.07% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| aTyr Pharma | 46.89M |
| Plus Therapeutics | 45.56M |
| Telomir Pharmaceuticals | 44.35M |
| Atossa Therapeutics | 44.09M |
| KALA BIO | 43.31M |
| Nutriband | 41.39M |
| NanoViricides | 39.87M |
| Veru Inc. | 37.40M |